Physician

Farzad H Sabet, MD

According to 2025 Medicare claims, Farzad Sabet, MD (NPI: 1164454591) practices physical medicine and rehabilitation in the Redding, CA market, with the plurality of this provider's patient population coming from Shasta, CA. This provider's primary affiliated billing organization is SHASTA ORTHOPEDICS & SPORTS MEDICINE A MEDICAL CORPORATION (NPI: 1750493979; TIN: 680310525) and primary practice location at 96001-0814.

Sabet's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,202 traditional Medicare patients, billed 26,589 HCPCS/CPT codes, and received $1,046,886 in Medicare payments. The top billing code was 62323 (Injection of substance into lower spine canal using imaging guidance). Part D data shows 901 prescription claims across 419 beneficiaries totaling $16,545 in drug costs, led by Gabapentin (Gabapentin). DME data shows 22 claims. Open Payments data shows 5 records totaling $132. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $93,694 to $16,545. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $5,254 to $834.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,159	31,610	$879,857
2016	1,194	37,214	$976,597
2017	1,355	47,911	$1,106,364
2018	1,487	46,319	$1,138,245
2019	1,474	30,119	$1,235,446
2020	1,327	30,938	$1,175,500
2021	1,295	26,392	$1,063,742
2022	1,115	20,815	$851,785
2023	1,166	22,426	$908,469
2024	1,202	26,589	$1,046,886

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	353	1,314	$93,694
2016	295	1,004	$60,926
2017	230	755	$36,498
2018	238	589	$20,368
2019	322	724	$18,160
2020	367	965	$14,959
2021	381	911	$9,754
2022	352	746	$5,523
2023	395	779	$4,130
2024	419	901	$16,545

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	12	12	$3,330
2017	N/R	N/R	N/R
2018	16	16	$4,885
2019	16	16	$4,997
2020	13	13	$4,142
2021	N/R	N/R	N/R
2022	N/R	19	$568
2023	N/R	19	$628
2024	N/R	22	$355

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
62323	Injection of substance into lower spine canal using imaging guidance	332	392	$199
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	639	1,349	$97
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	443	2,331	$6
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	490	3,759	$1
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	673	3,438	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gabapentin	Gabapentin	36	1,666	$727
Alprazolam	Alprazolam	560	663	$593
Celecoxib	Celecoxib	11	304	$490
Duloxetine Hcl	Duloxetine Hcl	64	2,570	$487
Pregabalin	Pregabalin	17	600	$401

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4595	Electrical stimulator supplies, 2 lead, per month, (e.g., tens, nmes)	N	N/R	22	$355

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$132	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Farzad H. Sabet, MD?

Tedicare shows public-source Medicare data for Farzad H. Sabet, MD (NPI 1164454591), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Farzad H. Sabet, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Farzad H. Sabet, MD?

Farzad H. Sabet, MD is linked to SHASTA ORTHOPEDICS & SPORTS MEDICINE A MEDICAL CORPORATION (billing NPI 1750493979) in the available physician profile data.

Does Farzad H. Sabet, MD have Open Payments data?

Farzad H. Sabet, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.